References and Notes
Recent reviews, see:
<A NAME="RU02407ST-1A">1a</A>
Chopade PR.
Louie J.
Adv. Synth. Catal.
2006,
348:
2307
<A NAME="RU02407ST-1B">1b</A>
Gandon V.
Aubert C.
Malacria M.
Chem. Commun.
2006,
2209
<A NAME="RU02407ST-1C">1c</A>
Kotha S.
Brahmachary E.
Lahiri K.
Eur. J. Org. Chem.
2005,
4741
<A NAME="RU02407ST-1D">1d</A>
Yamamoto Y.
Curr. Org. Chem.
2005,
9:
503
<A NAME="RU02407ST-1E">1e</A>
Varela JA.
Saá C.
Chem. Rev.
2003,
103:
3787
<A NAME="RU02407ST-1F">1f</A>
Saito S.
Yamamoto Y.
Chem. Rev.
2000,
100:
2901
<A NAME="RU02407ST-2">2</A> For a review of rhodium-catalyzed [2+2+2] cycloadditions, see:
Fujiwara M.
Ojima I. In
Modern Rhodium-Catalyzed Organic Reactions
Evans PA.
Wiley-VCH;
Weinheim:
2005.
Chap. 7.
p.129
<A NAME="RU02407ST-3">3</A> For pioneering work on RhCl(PPh3)3-catalyzed [2+2+2] cycloadditions, see:
Grigg R.
Scott R.
Stevenson P.
J. Chem. Soc., Perkin Trans. 1
1988,
1357
<A NAME="RU02407ST-4">4</A> For our first discovery of cationic rhodium(I)/modified-BINAP-catalyzed inter-
and intramolecular [2+2+2] cycloadditions, see:
Tanaka K.
Shirasaka K.
Org. Lett.
2003,
5:
4697
<A NAME="RU02407ST-5A">5a</A>
Tanaka K.
Nishida G.
Wada A.
Noguchi K.
Angew. Chem. Int. Ed.
2004,
43:
6510
<A NAME="RU02407ST-5B">5b</A>
Tanaka K.
Nishida G.
Ogino M.
Hirano M.
Noguchi K.
Org. Lett.
2005,
7:
3119
<A NAME="RU02407ST-5C">5c</A>
Tanaka K.
Wada A.
Noguchi K.
Org. Lett.
2005,
7:
4737
<A NAME="RU02407ST-5D">5d</A>
Nishida G.
Suzuki N.
Noguchi K.
Tanaka K.
Org. Lett.
2006,
8:
3489
<A NAME="RU02407ST-5E">5e</A>
Tanaka K.
Takeishi K.
Noguchi K.
J. Am. Chem. Soc.
2006,
128:
4586
<A NAME="RU02407ST-5F">5f</A>
Tanaka K.
Suda T.
Noguchi K.
Hirano M.
J. Org. Chem.
2007,
72:
2243
<A NAME="RU02407ST-6A">6a</A>
Tanaka K.
Sagae H.
Toyoda K.
Noguchi K.
Hirano M.
J. Am. Chem. Soc.
2007,
129:
1522
For Cationic rhodium(I)/H8-BINAP-catalyzed synthesis of achiral cyclophanes, see:
<A NAME="RU02407ST-6B">6b</A>
Tanaka K.
Toyoda K.
Wada A.
Shirasaka K.
Hirano M.
Chem. Eur. J.
2005,
11:
1145
<A NAME="RU02407ST-6C">6c</A>
Tanaka K.
Sagae H.
Toyoda K.
Noguchi K.
Eur. J. Org. Chem.
2006,
3575
<A NAME="RU02407ST-7A">7a</A>
Tanaka K.
Wada A.
Noguchi K.
Org. Lett.
2006,
8:
907
<A NAME="RU02407ST-7B">7b</A>
Tanaka K.
Suzuki N.
Nishida G.
Eur. J. Org. Chem.
2006,
3917
<A NAME="RU02407ST-7C">7c</A>
Tanaka K.
Osaka T.
Noguchi K.
Hirano M.
Org. Lett.
2007,
9:
1307
Preparation of chiral reagents by cationic rhodium(I)/modified-BINAP-catalyzed enantioselective
[2+2+2] cycloadditions:
<A NAME="RU02407ST-8A">8a</A> For spirobipyridine ligands, see:
Wada A.
Noguchi K.
Hirano M.
Tanaka K.
Org. Lett.
2007,
9:
1295
<A NAME="RU02407ST-8B">8b</A> For biaryl phosphorous ligands, see:
Nishida G.
Noguchi K.
Hirano M.
Tanaka K.
Angew. Chem. Int. Ed.
2007,
46:
in press; doi: 10.1002/anie.200700064
<A NAME="RU02407ST-9">9</A>
Grigg R.
Scott R.
Stevenson P.
J. Chem. Soc., Perkin Trans. 1
1988,
1365
<A NAME="RU02407ST-10">10</A> For RhCl(CO)(PPh3)2- or RhCl(PPh3)3-catalyzed intramolecular [2+2+2] cycloadditions of cyclic trans enediynes leading to C
2-symmetric tetracyclic cyclohexadienes, see:
Torrent A.
González I.
Pla-Quintana A.
Roglans A.
Moreno-Manas M.
Parella T.
Benet-Buchholz J.
J. Org. Chem.
2005,
70:
2033
For pioneering works on Co(I)-mediated intramolecular cycloadditions of 1,2-di-, 1,1,2-tri-,
and 1,1,2,2-tetrasubstituted enediynes, see:
<A NAME="RU02407ST-11A">11a</A>
Malacria M.
Vollhardt KPC.
J. Org. Chem.
1984,
49:
5010
<A NAME="RU02407ST-11B">11b</A>
Gadek TR.
Vollhardt KPC.
Angew. Chem., Int. Ed. Engl.
1981,
20:
802
<A NAME="RU02407ST-12">12</A>
Yamamoto Y.
Kuwabara S.
Ando Y.
Nagata H.
Nishiyama H.
Itoh K.
J. Org. Chem.
2004,
69:
6697
<A NAME="RU02407ST-13A">13a</A>
Chiusoli GP.
Costa M.
Zhou Z.
Gazz. Chim. Ital.
1992,
122:
441
<A NAME="RU02407ST-13B">13b</A>
Zhou Z.
Battaglia LP.
Chiusoli GP.
Costa M.
Nardelli M.
Pelizzi C.
Predieri G.
J. Chem. Soc., Chem. Commun.
1990,
1632
<A NAME="RU02407ST-13C">13c</A>
Grotjahn DB.
Vollhardt KPC.
Synthesis
1993,
579
<A NAME="RU02407ST-13D">13d</A>
Vollhardt KPC.
Angew. Chem., Int. Ed. Engl.
1984,
23:
539
<A NAME="RU02407ST-14">14</A>
Zhang X.
Mashima K.
Koyano K.
Sayo N.
Kumobayashi H.
Akutagawa S.
Takaya H.
Tetrahedron Lett.
1991,
32:
7283
<A NAME="RU02407ST-15">15</A> For asymmetric synthesis of planar-chiral cyclic ethers, see:
Tomooka K.
Komine N.
Fujiki D.
Nakai T.
Yanagitsuru S.
J. Am. Chem. Soc.
2005,
127:
12812
<A NAME="RU02407ST-16">16</A>
General Procedure for Intramolecular [2+2+2] Cycloadditions (Table 1): Under an Ar atmosphere, BINAP-type ligand (0.0125 mmol) and [Rh(cod)2]BF4 (cod: 1,5-cyclooctadiene; 0.0125 mmol) were dissolved in CH2Cl2 (2.0 mL) and the mixture was stirred at r.t. for 5 min. H2 (1 atm) was introduced to the resulting solution in a Schlenk tube. After stirring
at r.t. for 0.5 h, the resulting solution was concentrated and redissolved in CH2Cl2 (8.0 mL). To this solution was added dropwise over 10 min a solution of 1 (0.125 mmol) in CH2Cl2 (2.0 mL), and the remaining substrate was washed away by using CH2Cl2 (2.5 mL). After stirring at r.t. for 16 h, the resulting solution was concentrated
and product 2 was isolated by preparative TLC. Product (-)-2a: [α]25
D -31.0° (acetone, c = 0.010; 48% ee). IR (neat): 3390, 2930, 2860, 2360, 1730, 1680, 1040, 900 cm-1. 1H NMR (300 MHz, CDCl3): δ = 5.86 (s, 2 H), 4.55 (d, J = 13.8 Hz, 2 H), 4.35 (d, J = 13.8 Hz, 2 H), 4.23-4.31 (m, 2 H), 3.41-3.53 (m, 2 H), 2.63-2.81 (m, 2 H). HRMS
(ESI): m/z [M]+ calcd for C10H12O2: 164.0837; found: 164.0841. HPLC: CHIRALPAK AD-H; hexane-i-PrOH = 99:1; 1.0 mL/min, t
R
= 12.6 min (major isomer), t
R
= 13.5 min (minor isomer). Product (+)-2b: [α]25
D +64.9° (acetone, c = 0.665, 59% ee). IR (neat): 3390, 2950, 2850, 1720, 1440, 1300, 1210, 1150, 1020,
920 cm-1. 1H NMR (300 MHz, CDCl3): δ = 4.98 (d, J = 17.4 Hz, 2 H), 4.52 (d, J = 17.4 Hz, 2 H), 4.25-4.36 (m, 2 H), 3.76 (s, 6 H), 3.41-3.50 (m, 2 H), 2.84-3.02
(m, 2 H). 13C NMR (CDCl3, 75 MHz): δ = 165.4, 155.8, 120.5, 72.8, 70.3, 51.9, 45.4. HRMS (ESI): m/z [M]+ calcd for C14H16O6: 280.0947; found: 280.0988. HPLC: CHIRALPAK AS; hexane-2-PrOH = 95:5; 1.0 mL/min;
t
R
= 29.3 min (major isomer), t
R
= 39.0 min (minor isomer).
<A NAME="RU02407ST-17">17</A>
General Procedure for Intermolecular [2+2+2] Cycloadditions (Table 2): Under an Ar atmosphere, BINAP-type ligand (0.010 mmol) and [Rh(cod)2]BF4 (0.010 mmol) were dissolved in CH2Cl2 (2.0 mL) and the mixture was stirred at r.t. for 5 min. H2 (1 atm) was introduced to the resulting solution in a Schlenk tube. After stirring
at r.t. for 0.5 h, the resulting solution was concentrated and redissolved in CH2Cl2 (0.5 mL). To this solution was added a CH2Cl2 (0.5 mL) solution of 13 (1.00 mmol) and then a CH2Cl2 (1.0 mL) solution of 12 (0.20 mmol) was added dropwise over 20 min at r.t. After stirring at r.t. for 1 h,
the resulting solution was concentrated and product 14 was isolated by preparative TLC. Product (-)-14a: mp 41.0-41.9 °C; [α]25
D -334.7° (c = 1.53, CHCl3; 90% ee). IR (neat): 2953, 1731, 1434, 1253, 1206, 1169, 1007 cm-1. 1H NMR (300 MHz, CDCl3): δ = 4.50 (d, J = 12.9 Hz, 2 H), 4.43 (d, J = 12.9 Hz, 2 H), 3.68 (s, 6 H), 3.55 (s, 2 H), 1.82 (s, 6 H). 13C NMR (75 MHz, CDCl3): δ = 172.7, 132.4, 117.3, 70.0, 52.2, 47.8, 19.2. HPLC: CHIRALCEL OD-H, hexane-i-PrOH = 97:3; 1.0 mL/min; t
R
= 10.2 min (minor isomer),
t
R
= 11.8 min (major isomer). Product (-)-14b: mp 128.9-130.5 °C; [α]25
D -175.2° (c = 4.78, CHCl3; 82% ee). IR (neat): 2952, 1732, 1430, 1346, 1305, 1259, 1160 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.73 (d, J = 7.8 Hz, 2 H), 7.35 (d, J = 7.8 Hz, 2 H), 3.98 (d, J = 12.6 Hz, 2 H), 3.91 (d, J = 12.6 Hz, 2 H), 3.91 (s, 6 H), 3.52 (s, 2 H), 2.44 (s, 3 H), 1.81 (s, 6 H). 13C NMR (75 MHz, CDCl3): δ = 172.1, 143.6, 132.9, 129.7, 129.0, 127.6, 120.0, 52.2, 50.1, 47.2, 21.4, 19.1.
HPLC: CHIRALPAK AD-H, hexane-i-PrOH = 90:10; 1.0 mL/min; t
R
= 21.0 min (major isomer), t
R
= 23.5 min (minor isomer). Product (-)-14c: [α]25
D -229.0° (c = 0.59, CHCl3; 98% ee). IR (neat): 2954, 1733, 1435, 1253, 1201, 1165 cm-1. 1H NMR (300 MHz, CDCl3): δ = 3.72 (s, 6 H), 3.66 (s, 6 H), 3.50 (s, 2 H), 3.01 (d, J = 16.5 Hz, 2 H), 2.94 (d, J = 16.5 Hz, 2 H), 1.85 (s, 6 H). 13C NMR (75 MHz, CDCl3): δ = 172.9, 171.8, 132.4, 119.8, 58.7, 52.8, 52.1, 47.9, 37.1, 19.2. HPLC: CHIRALPAK
AD-H, hexane-i-PrOH = 97:3; 1.0 mL/min; t
R
= 12.5 min (major isomer),
t
R
= 15.9 min (minor isomer).
<A NAME="RU02407ST-18">18</A>
Products 16 and (-)-17: [α]25
D -25.3° {CHCl3, c = 0.160 [based on the calculated content of (-)-17], >99% ee}. 1H NMR (300 MHz, CDCl3): δ = 3.81 (d, J = 12.6 Hz, 2 H, 17), 3.80 (d, J = 12.6 Hz, 2 H, 16), 3.58 (d, J = 12.6 Hz, 2 H, 17), 3.57 (d, J = 12.6 Hz, 2 H, 16), 3.43 (d, J = 9.0 Hz, 2 H, 17), 3.27 (d, J = 9.0 Hz, 2 H, 16), 2.74 (d, J = 9.0 Hz, 2 H, 17), 2.59 (d, J = 9.0 Hz, 2 H, 16), 2.44 (s, 6 H, 16), 2.43 (s, 6 H, 17), 1.48-1.63 (m, 2 H + 2 H, 16 + 17), 1.19-1.33 (m, 2 H + 2 H, 16 + 17), 0.90 (s, 6 H + 6 H, 16 + 17). HPLC: CHIRALPAK AD-H, hexane-i-PrOH = 90:10; 1.0 mL/min; t
R
= 81.8 min [minor dl-isomer (+)-17], t
R
= 98.5 min (meso-isomer 16), t
R
= 109.8 min [major dl-isomer (-)-17].